Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
Stem cell scientists have moved one step closer to producing blood-forming stem cells in a Petri dish by identifying a key regulator controlling their formation in the early embryo, shows research published online in Cell.
The work was reported by Dr. Gordon Keller, Director of the McEwen Centre for Regenerative Medicine, and Senior Scientist at Princess Margaret Cancer Centre, both at University Health Network. Dr. Keller is also Professor in the Department of Medical Biophysics at the University of Toronto and holds a Canada Research Chair in stem cell biology.
Using mouse models to study the process of blood cell development, Dr. Keller and his team demonstrated that the retinoic acid signalling pathway is required for formation of blood-forming stem cells. Retinoic acid is produced from vitamin A and is essential for many areas of human growth and development.
When the researchers genetically disrupted the pathway that produces retinoic acid in mice, no blood-forming stem cells were produced. When they activated the pathway at the precise stage when stem cells develop, they observed a large increase in the number of blood-forming stem cells.
"Understanding how different cells and tissues are made in the embryo provides important clues for producing human cell types from pluripotent stem cells in a Petri dish," says Dr. Keller. Pluripotent stem cells are master stem cells that are able to generate many different cell types including heart, blood, pancreas and liver. To make a specific cell type from pluripotent stem cells, one must direct them down the appropriate developmental path in the Petri dish.
Dr. Keller adds: "Our findings have identified a critical regulator for directing pluripotent stem cells to make blood-forming stem cells, bringing us one step closer to our goal of developing a new and unlimited source of these stem cells for transplantation for the treatment of different blood cell diseases."
This research was funded by the Canadian Institutes of Health Research and the U.S.-based National Institutes of Health. Dr. Keller's research is also supported by the McEwen Centre for Regenerative Medicine, The Toronto General & Western Hospital Foundation, and The Princess Margaret Cancer Foundation.
Cell, Volume 155, Issue 1, 215-227, 26 September 2013 10.1016/j.cell.2013.08.055
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Blood / Hematology category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University Health Network. "Critical regulator identified for directing pluripotent stem cells to make blood-forming stem cells." Medical News Today. MediLexicon, Intl., 30 Sep. 2013. Web.
12 Dec. 2013. <http://www.medicalnewstoday.com/releases/266694>
University Health Network. (2013, September 30). "Critical regulator identified for directing pluripotent stem cells to make blood-forming stem cells." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact the our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/266694.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2013 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.